All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Efficacy and immunogenicity of a veterinary vaccine candidate against tick-borne encephalitis in dogs

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00027162%3A_____%2F23%3AN0000163" target="_blank" >RIV/00027162:_____/23:N0000163 - isvavai.cz</a>

  • Alternative codes found

    RIV/60077344:_____/23:00579681 RIV/00216224:14310/23:00132670 RIV/62157124:16170/23:43881032

  • Result on the web

    <a href="https://www.sciencedirect.com/science/article/pii/S0264410X23010897?via%3Dihub" target="_blank" >https://www.sciencedirect.com/science/article/pii/S0264410X23010897?via%3Dihub</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1016/j.vaccine.2023.09.019" target="_blank" >10.1016/j.vaccine.2023.09.019</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Efficacy and immunogenicity of a veterinary vaccine candidate against tick-borne encephalitis in dogs

  • Original language description

    Tick-borne encephalitis (TBE) is a severe neuroinfection of humans that occurs in Europe and Asia. Dogs are also commonly infected with tick-borne encephalitis virus (TBEV) in TBE-endemic areas. These infections are usually asymptomatic, but sometimes show clinical signs similar to those seen in humans and can be fatal. To date, there is no TBEV vaccine available for use in dogs. To address this unmet need, we have developed a TBEV vaccine candidate for dogs based on inactivated whole virus antigen. The safety, immunogenicity, and efficacy of the vaccine candidate were tested in mice as the preclinical model and in dogs as the target organism. The vaccine was well tolerated in both animal species and elicited the production of specific anti-TBEV antibodies with virus neutralising activity. Vaccination of mice provided complete protection against the development of fatal TBE. Immunisation of dogs prevented the development of viremia after challenge infection. Therefore, the developed vaccine candidate is promising to protect dogs from severe TBEV infections.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    10607 - Virology

Result continuities

  • Project

    Result was created during the realization of more than one project. More information in the Projects tab.

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2023

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Vaccine

  • ISSN

    0264-410X

  • e-ISSN

    1873-2518

  • Volume of the periodical

    41

  • Issue of the periodical within the volume

    42

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    6

  • Pages from-to

    6150-6155

  • UT code for WoS article

    001089063300001

  • EID of the result in the Scopus database

    2-s2.0-85171657807